Sélectionnez votre langue

From experimental pharmacology to early-stage clinical development: understanding how drug candidates move from the lab to human studies.

 

As part of the VISION Project, we are pleased to announce an upcoming in-person training, taking place from 18 to 21 May, 2026

This 4-day course will cover the key steps of the drug development pathway, from pharmacological principles and formulation to clinical pharmacology and the transition from preclinical research into first-in-human studies.

We are honored to welcome a distinguished panel of speakers:
• Francois-Xavier Lacasse, Lecturer in practical training, Faculty of Pharmacy, Université de Montréal
• Myriam Razgallah Khrouf, Professor of Pharmacology at the Faculty of Pharmacy Monastir / Director of Medical Research at Ministère de la santé publique | Tunisie
• Mohamed Bejaoui, Assistant Professor of Pharmacology at the University of Monastir.
• Sameh Ben Tkhayat, Senior Pharmacist, Deputy Director at Ministère de la santé publique | Tunisie
• nizar laabidi, Head of the Vaccine and Therapeutic Serum Production Unit, Institut Pasteur de Tunis 
• Abdelhamid CHIRCHI, Senior Engineer / Member of the Steering Committee for the mRNA-based Products Research and Development Unit, Institut Pasteur de Tunis  
• Emna Harigua, Reseach Team Leader, Department of Molecular Epidemiology and Experimental Pathology, Institut Pasteur de Tunis 
• Jihene BETTAIEB, Head of the Medical Epidemiology Laboratory, Institut Pasteur de Tunis 
• Erij Messadi, Professor at the Biomolecules, Venoms and Theranostic Applications Laboratory, Institut Pasteur de Tunis 


• Sonia Sebai, Head of the National Control Laboratory at Tunisia's National Regulatory Authority
• Mariem Kadri, Pharmacist, Directorate of Pharmacy and Medicine , ANMPS TUNISIA
• Chokri Jeribi, Chief Scientific Officer & Corporate Affairs, President of National CROs Chamber

This training is designed for researchers, and professionals aiming to strengthen their understanding of translational pharmacology and early clinical development.

Maximum capacity: 50 participants only 
In person in Tunisia, (further details regarding the venue will be communicated directly to accepted participants)
18–21 May, 2026

Register here by May 13: https://lnkd.in/dDFV_HXb

 

Contacts

13, place Pasteur, B.P. 74 1002 Tunis, Belvédère Tunisie

E-mail : info@pasteur.tn

Téléphone : +216 71783 022 / +216 71 843 755